Practical p-value adjustment for optimally selected cutpoints

Statistics in Medicine

Volumn 15, Issue 1, 1996, Pages 103-112

  Hilsenbeck, Susan Galloway ^a   Clark, Gary M ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN; MARKER;

ARTICLE; BREAST CANCER; HUMAN; PROGNOSIS; SIMULATION;

BIAS (EPIDEMIOLOGY); BIOLOGICAL MARKERS; BREAST NEOPLASMS; DATA INTERPRETATION, STATISTICAL; EFFECT MODIFIERS (EPIDEMIOLOGY); FEMALE; HSP70 HEAT-SHOCK PROTEINS; HUMANS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REPRODUCIBILITY OF RESULTS; SURVIVAL ANALYSIS;

EID: 0030057525     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0258(19960115)15:1<103::AID-SIM156>3.0.CO;2-Y     Document Type: Article

References (25)

1. Hedley, D. W., Clark, G. M., Cornelisse, C. J., Killander, D., Kute, T. and Merkel, D. 'Consensus review of the clinical utility of DNA cytometry in carcinoma of the breast', Cytometry, 14, 482-485 (1993).
2. 'Treatment of early-stage breast cancer', NIH Consensus Statement, 8, 1-19 (1990).
3. Simon, R. and Altman, D. G. 'Statistical aspects of prognostic factor studies in oncology', British Journal of Cancer, 69, 979-985 (1994).
4. Hermanek, P. and Sobin, L. H., (eds) TNM Classification of Malignant Tumours, 4th edn, Springer-Verlag, New York, 1987.
5. Lausen, B. and Schumacher, M. 'Maximally selected rank statistics', Biometrics, 48, 73-85 (1992).
6. Altman, D. G., Lausen, B., Sauerbrei, W. and Schumacher, M. 'Dangers of using "optimal cutpoints" in the evaluation of prognostic factor', Journal of the National Cancer Institute, 86, 829-835 (1994).
7. Lausen, B. and Schumacher, M. 'Evaluating the effect of optimized cutoff values in the assessment of prognostic factors', Technical Report, Institut fur Medizinische Biometrie und Medizinische Informatik, Klinikum der Albert-Ludwigs-Universitat Freiberg, June, 1993.
8. Hilsenbeck, S. G., Clark, G. M. and McGuire, W. L. 'Why do so many prognostic factors fail to pan out?', Breast Cancer Research and Treatment, 22, 197-206 (1992).
9. McGuire, W. L. 'Breast cancer prognostic factors: Evaluation guidelines', Journal of the National Cancer Institute, 83, 184-185 (1991).
10. Schulgen, G., Lausen, B., Olsen, J. H. and Schumacher, M. 'Outcome-oriented cutpoints in analysis of quantitative exposures', American Journal of Epidemiology, 140, 172-184 (1994).
11. Hunter, D. 'An upper bound for the probability of a union', Journal of Applied Probability, 13, 597-603 (1976).
12. Worsley, K. J. 'An improved Bonferroni inequality and applications', Biometrika, 69, 297-302 (1982).
13. Ravdin, P. M., Tandon, A. K., Allred, D. C., Clark, G. M., Fuqua, S. W., Hilsenbeck, S. G., Chamness, G. C. and Osborne, C. K. 'Cathepsin D by western blotting and immunohistochemistry: failure to confirm correlations with prognosis in node-negative breast cancer', Journal of Clinical Oncology, 12, 467-474 (1994).
14. LeBlanc, M. 'Recursive partitioning for censored survival data', Dissertation, University of Washington, 1989.
15. Lachin, J. M. and Foulkes, M. A. 'Evaluation of sample size and power for analyses of survival with allowance for nonuniform patient entry, losses to followup, noncompliance, and stratification', Biometrics, 42, 507-519 (1986).
16. Ciocca, D. R., Clark, G. M., Tandon, A. K., Fuqua, S. A. W., Welch, W. and McGuire, W. L. 'Heat shock protein hsp70 in patients with axillary lymph node-negative breast cancer. Prognostic implications', Journal of the National Cancer Institute, 85, 570-574 (1993).
17. Hastie, T. and Tibshirani, R. 'Generalized additive models', Statistical Science, 1, 297-318 (1986).
18. Hastie, T. and Tibshirani, R. 'Exploring the nature of covariate effects in the proportional hazards model', Biometrics, 46, 1005-1016 (1990).
19. Therneau, T. M., Grambsch, P. M. and Fleming, T. R. 'Martingale-based residuals for survival models', Biometrika, 77, 147-160 (1990).
20. Gentleman, R. and Crowley, J. 'Graphical methods for censored data', Journal of the American Statistical Association, 86, 678-683 (1991).
21. Foekens, J. A., Schmitt, M., van Putten, W. L. J., Peters, H. A., Kramer, M. D., Janicke, F. and Klijn, J. G. M. 'Plasminogen activator inhibitor-1 and prognosis in primary breast cancer', Journal of Clinical Oncology, 12, 1648-1658 (1994).
22. Clarke, D. M. and McKenzie, D. P. 'A caution on the use of cut-points applied to screening instruments or diagnostic criteria', Journal of Psychiatric Research, 28, 185-188 (1994).
23. Breiman, L., Friedman, J. H. and Olshen, R. A. Classification and Regression Trees, Wadsworth, Belmont, CA, 1984.
24. Segal, M. R. 'Regression trees for censored data', Biometrics, 44, 35-47 (1988).
25. Albain, K. S., Crowley, J. J., LeBlanc, M. and Livingston, R. B. 'Survival determinants in extensive-stage non-small-cell lung cancer: The Southwest Oncology Group experience', Journal of Clinical Oncology, 9, 1618-1626 (1991).